| Year |
Citation |
Score |
| 2024 |
Biedenkopf N, Bukreyev A, Chandran K, Di Paola N, Formenty PBH, Griffiths A, Hume AJ, Mühlberger E, Netesov SV, Palacios G, Pawęska JT, Smither S, Takada A, Wahl V, Kuhn JH. ICTV Virus Taxonomy Profile: 2024. The Journal of General Virology. 105. PMID 38305775 DOI: 10.1099/jgv.0.001955 |
0.33 |
|
| 2023 |
Santos RI, Ilinykh PA, Pietzsch CA, Ronk AJ, Huang K, Kuzmina NA, Zhou F, Crowe JE, Bukreyev A. Blocking of ebolavirus spread through intercellular connections by an MPER-specific antibody depends on BST2/tetherin. Cell Reports. 42: 113254. PMID 37858466 DOI: 10.1016/j.celrep.2023.113254 |
0.373 |
|
| 2023 |
Baldeon Vaca G, Meyer M, Cadete A, Hsiao CJ, Golding A, Jeon A, Jacquinet E, Azcue E, Guan CM, Sanchez-Felix X, Pietzsch CA, Mire CE, Hyde MA, Comeaux ME, Williams JM, ... ... Bukreyev A, et al. Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection. Science Advances. 9: eadh1655. PMID 37738334 DOI: 10.1126/sciadv.adh1655 |
0.316 |
|
| 2023 |
Ronk AJ, Lloyd NM, Zhang M, Atyeo C, Perrett HR, Mire CE, Hastie KM, Sanders RW, Brouwer PJM, Saphire EO, Ward AB, Ksiazek TG, Alvarez Moreno JC, Thaker HM, Alter G, ... ... Bukreyev A, et al. A Lassa virus mRNA vaccine confers protection but does not require neutralizing antibody in a guinea pig model of infection. Nature Communications. 14: 5603. PMID 37699929 DOI: 10.1038/s41467-023-41376-6 |
0.454 |
|
| 2023 |
Iampietro M, Amurri L, Reynard O, Bukreyev A. Interplay of Ebola Virus With Immune Cells Leading to Their Death by Diverse Mechanisms. The Journal of Infectious Diseases. 228: S582-S586. PMID 37654044 DOI: 10.1093/infdis/jiad377 |
0.345 |
|
| 2023 |
Malherbe DC, Kimble JB, Atyeo C, Fischinger S, Meyer M, Cody SG, Hyde M, Alter G, Bukreyev A. A single dose intranasal combination panebolavirus vaccine. The Journal of Infectious Diseases. PMID 37469133 DOI: 10.1093/infdis/jiad266 |
0.308 |
|
| 2023 |
Bukreyev A, Ilinykh P, Huang K, Gunn B, Kuzmina N, Gilchuk P, Alter G, Crowe J. Antiviral protection by antibodies targeting the glycan cap of Ebola virus glycoprotein requires activation of the complement system. Research Square. PMID 37131834 DOI: 10.21203/rs.3.rs-2765936/v1 |
0.374 |
|
| 2023 |
Chen EC, Gilchuk P, Zost SJ, Ilinykh PA, Binshtein E, Huang K, Myers L, Bonissone S, Day S, Kona CR, Trivette A, Reidy JX, Sutton RE, Gainza C, Diaz S, ... ... Bukreyev A, et al. Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes. Cell Reports. 42: 112370. PMID 37029928 DOI: 10.1016/j.celrep.2023.112370 |
0.336 |
|
| 2023 |
Engdahl TB, Binshtein E, Brocato RL, Kuzmina NA, Principe LM, Kwilas SA, Kim RK, Chapman NS, Porter MS, Guardado-Calvo P, Rey FA, Handal LS, Diaz SM, Zagol-Ikapitte IA, Tran MH, ... ... Bukreyev A, et al. Antigenic mapping and functional characterization of human new world hantavirus neutralizing antibodies. Elife. 12. PMID 36971354 DOI: 10.7554/eLife.81743 |
0.366 |
|
| 2023 |
Jayaprakash AD, Ronk AJ, Prasad AN, Covington MF, Stein KR, Schwarz TM, Hekmaty S, Fenton KA, Geisbert TW, Basler CF, Bukreyev A, Sachidanandam R. Marburg and Ebola Virus Infections Elicit a Complex, Muted Inflammatory State in Bats. Viruses. 15. PMID 36851566 DOI: 10.3390/v15020350 |
0.369 |
|
| 2022 |
Bartsch YC, Cizmeci D, Kang J, Zohar T, Periasamy S, Mehta N, Tolboom J, Van der Fits L, Sadoff J, Comeaux C, Callendret B, Bukreyev A, Lauffenburger DA, Bastian AR, Alter G. Antibody effector functions are associated with protection from respiratory syncytial virus. Cell. 185: 4873-4886.e10. PMID 36513064 DOI: 10.1016/j.cell.2022.11.012 |
0.396 |
|
| 2022 |
Brouwer PJM, Antanasijevic A, Ronk AJ, Müller-Kräuter H, Watanabe Y, Claireaux M, Perrett HR, Bijl TPL, Grobben M, Umotoy JC, Schriek AI, Burger JA, Tejjani K, Lloyd NM, Steijaert TH, ... ... Bukreyev A, et al. Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection. Cell Host & Microbe. PMID 36400021 DOI: 10.1016/j.chom.2022.10.018 |
0.368 |
|
| 2022 |
Liu Y, Zhang X, Liu J, Xia H, Zou J, Muruato AE, Periasamy S, Kurhade C, Plante JA, Bopp NE, Kalveram B, Bukreyev A, Ren P, Wang T, Menachery VD, et al. A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions. Nature Communications. 13: 4337. PMID 35896528 DOI: 10.1038/s41467-022-31930-z |
0.438 |
|
| 2022 |
van Tol S, Kalveram B, Ilinykh PA, Ronk A, Huang K, Aguilera-Aguirre L, Bharaj P, Hage A, Atkins C, Giraldo MI, Wakamiya M, Gonzalez-Orozco M, Warren AN, Bukreyev A, Freiberg AN, et al. Ubiquitination of Ebola virus VP35 at lysine 309 regulates viral transcription and assembly. Plos Pathogens. 18: e1010532. PMID 35533195 DOI: 10.1371/journal.ppat.1010532 |
0.346 |
|
| 2022 |
Ilinykh PA, Periasamy S, Huang K, Kuzmina NA, Ramanathan P, Meyer MN, Mire CE, Kuzmin IV, Bharaj P, Endsley JR, Chikina M, Sealfon SC, Widen SG, Endsley MA, Bukreyev A. A single intranasal dose of human parainfluenza virus type 3-vectored vaccine induces effective antibody and memory T cell response in the lungs and protects hamsters against SARS-CoV-2. Npj Vaccines. 7: 47. PMID 35468973 DOI: 10.1038/s41541-022-00471-3 |
0.386 |
|
| 2022 |
Fang J, Pietzsch C, Tsaprailis G, Crynen G, Cho KF, Ting AY, Bukreyev A, de la Torre JC, Saphire EO. Functional interactomes of the Ebola virus polymerase identified by proximity proteomics in the context of viral replication. Cell Reports. 38: 110544. PMID 35320713 DOI: 10.1016/j.celrep.2022.110544 |
0.339 |
|
| 2022 |
Milligan JC, Davis CW, Yu X, Ilinykh PA, Huang K, Halfmann PJ, Cross RW, Borisevich V, Agans KN, Geisbert JB, Chennareddy C, Goff AJ, Piper AE, Hui S, Shaffer KCL, ... ... Bukreyev A, et al. Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses. Cell. 185: 995-1007.e18. PMID 35303429 DOI: 10.1016/j.cell.2022.02.023 |
0.346 |
|
| 2022 |
Liu Y, Zhang X, Liu J, Xia H, Zou J, Muruato AE, Periasamy S, Plante JA, Bopp NE, Kurhade C, Bukreyev A, Ren P, Wang T, Vineet D M, Plante KS, et al. A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions. Biorxiv : the Preprint Server For Biology. PMID 35194609 DOI: 10.1101/2022.02.14.480460 |
0.437 |
|
| 2021 |
Kuzmin IV, Ramanathan P, Basler CF, Bukreyev A. Effects of Overexpression of the Egyptian Fruit Bat Innate Immune Genes on Filovirus Infections in the Host Cells. Frontiers in Virology. 1. PMID 36237518 DOI: 10.3389/fviro.2021.759655 |
0.345 |
|
| 2021 |
Gilchuk P, Murin CD, Cross RW, Ilinykh PA, Huang K, Kuzmina N, Borisevich V, Agans KN, Geisbert JB, Zost SJ, Nargi RS, Sutton RE, Suryadevara N, Bombardi RG, Carnahan RH, ... Bukreyev A, et al. Pan-ebolavirus protective therapy by two multifunctional human antibodies. Cell. 184: 5593-5607.e18. PMID 34715022 DOI: 10.1016/j.cell.2021.09.035 |
0.327 |
|
| 2021 |
Meyer M, Wang Y, Edwards D, Smith GR, Rubenstein AB, Ramanathan P, Mire CE, Pietzsch C, Chen X, Ge Y, Cheng WS, Henry C, Woods A, Ma L, Stewart-Jones GB, ... ... Bukreyev A, et al. Attenuated activation of pulmonary immune cells in mRNA-1273 vaccinated hamsters after SARS-CoV-2 infection. The Journal of Clinical Investigation. PMID 34449440 DOI: 10.1172/JCI148036 |
0.32 |
|
| 2021 |
Gilchuk P, Guthals A, Bonissone SR, Shaw JB, Ilinykh PA, Huang K, Bombardi RG, Liang J, Grinyo A, Davidson E, Chen EC, Gunn BM, Alter G, Saphire EO, Doranz BJ, ... Bukreyev A, et al. Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human Plasma. Frontiers in Immunology. 12: 706757. PMID 34335620 DOI: 10.3389/fimmu.2021.706757 |
0.316 |
|
| 2021 |
Malherbe DC, Kurup D, Wirblich C, Ronk AJ, Mire C, Kuzmina N, Shaik N, Periasamy S, Hyde MA, Williams JM, Shi PY, Schnell MJ, Bukreyev A. A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19. Npj Vaccines. 6: 91. PMID 34294728 DOI: 10.1038/s41541-021-00352-1 |
0.363 |
|
| 2021 |
Ilinykh PA, Bukreyev A. Antibody responses to filovirus infections in humans: protective or not? The Lancet. Infectious Diseases. PMID 34175003 DOI: 10.1016/S1473-3099(21)00006-2 |
0.362 |
|
| 2021 |
Engdahl TB, Kuzmina NA, Ronk AJ, Mire CE, Hyde MA, Kose N, Josleyn MD, Sutton RE, Mehta A, Wolters RM, Lloyd NM, Valdivieso FR, Ksiazek TG, Hooper JW, Bukreyev A, et al. Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection. Cell Reports. 35: 109086. PMID 33951434 DOI: 10.1016/j.celrep.2021.109086 |
0.342 |
|
| 2021 |
Kurup D, Malherbe DC, Wirblich C, Lambert R, Ronk AJ, Zabihi Diba L, Bukreyev A, Schnell MJ. Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model. Plos Pathogens. 17: e1009383. PMID 33765062 DOI: 10.1371/journal.ppat.1009383 |
0.329 |
|
| 2021 |
Meyer M, Wang Y, Edwards D, Smith GR, Rubenstein AB, Ramanathan P, Mire CE, Pietzsch C, Chen X, Ge Y, Cheng WS, Henry C, Woods A, Ma L, Stewart-Jones GBE, ... ... Bukreyev A, et al. mRNA-1273 efficacy in a severe COVID-19 model: attenuated activation of pulmonary immune cells after challenge. Biorxiv : the Preprint Server For Biology. PMID 33532780 DOI: 10.1101/2021.01.25.428136 |
0.302 |
|
| 2021 |
Atyeo C, Slein MD, Fischinger S, Burke J, Schäfer A, Leist SR, Kuzmina NA, Mire C, Honko A, Johnson R, Storm N, Bernett M, Tong P, Zuo T, Lin J, ... ... Bukreyev A, et al. Dissecting strategies to tune the therapeutic potential of SARS-CoV-2-specific monoclonal antibody CR3022. Jci Insight. 6. PMID 33427208 DOI: 10.1172/jci.insight.143129 |
0.316 |
|
| 2020 |
Malherbe DC, Domi A, Hauser MJ, Meyer M, Gunn BM, Alter G, Bukreyev A, Guirakhoo F. Modified vaccinia Ankara vaccine expressing Marburg virus-like particles protects guinea pigs from lethal Marburg virus infection. Npj Vaccines. 5: 78. PMID 34471139 DOI: 10.1038/s41541-020-00226-y |
0.351 |
|
| 2020 |
Bozhanova NG, Sangha AK, Sevy AM, Gilchuk P, Huang K, Nargi RS, Reidy JX, Trivette A, Carnahan RH, Bukreyev A, Crowe JE, Meiler J. Discovery of Marburg virus neutralizing antibodies from virus-naïve human antibody repertoires using large-scale structural predictions. Proceedings of the National Academy of Sciences of the United States of America. PMID 33229516 DOI: 10.1073/pnas.1922654117 |
0.371 |
|
| 2020 |
Malherbe DC, Domi A, Hauser MJ, Meyer M, Gunn BM, Alter G, Bukreyev A, Guirakhoo F. Modified vaccinia Ankara vaccine expressing Marburg virus-like particles protects guinea pigs from lethal Marburg virus infection. Npj Vaccines. 5: 78. PMID 32922962 DOI: 10.1038/s41541-020-00226-y |
0.351 |
|
| 2020 |
Whitfield ZJ, Prasad AN, Ronk AJ, Kuzmin IV, Ilinykh PA, Andino R, Bukreyev A. Species-Specific Evolution of Ebola Virus during Replication in Human and Bat Cells. Cell Reports. 32: 108028. PMID 32814037 DOI: 10.1016/J.Celrep.2020.108028 |
0.498 |
|
| 2020 |
Prasanth KR, Hirano M, Fagg WS, McAnarney ET, Shan C, Xie X, Hage A, Pietzsch CA, Bukreyev A, Rajsbaum R, Shi PY, Bedford MT, Bradrick SS, Menachery V, Garcia-Blanco MA. Topoisomerase III-ß is required for efficient replication of positive-sense RNA viruses. Antiviral Research. 104874. PMID 32735900 DOI: 10.1016/J.Antiviral.2020.104874 |
0.418 |
|
| 2020 |
Su Z, Chang Q, Drelich A, Shelite T, Judy B, Liu Y, Xiao J, Zhou C, He X, Jin Y, Saito T, Tang S, Soong L, Wakamiya M, Fang X, ... Bukreyev A, et al. Annexin A2 depletion exacerbates the intracerebral microhemorrhage induced by acute rickettsia and Ebola virus infections. Plos Neglected Tropical Diseases. 14: e0007960. PMID 32687500 DOI: 10.1371/Journal.Pntd.0007960 |
0.383 |
|
| 2020 |
Prasanth KR, Hirano M, Fagg WS, McAnarney ET, Shan C, Xie X, Hage A, Pietzsch CA, Bukreyev A, Rajsbaum R, Shi PY, Bedford MT, Bradrick SS, Menachery V, Garcia-Blanco MA. Topoisomerase III-ß is required for efficient replication of positive-sense RNA viruses. Biorxiv : the Preprint Server For Biology. PMID 32511318 DOI: 10.1101/2020.03.24.005900 |
0.312 |
|
| 2020 |
Ilinykh PA, Huang K, Santos RI, Gilchuk P, Gunn BM, Karim MM, Liang J, Fouch ME, Davidson E, Parekh DV, Kimble JB, Pietzsch CA, Meyer M, Kuzmina NA, Zeitlin L, ... ... Bukreyev A, et al. Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies. Cell Host & Microbe. PMID 32320678 DOI: 10.1016/J.Chom.2020.03.025 |
0.488 |
|
| 2020 |
Gilchuk P, Murin CD, Milligan JC, Cross RW, Mire CE, Ilinykh PA, Huang K, Kuzmina N, Altman PX, Hui S, Gunn BM, Bryan AL, Davidson E, Doranz BJ, Turner HL, ... ... Bukreyev A, et al. Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization. Immunity. PMID 32023489 DOI: 10.1016/J.Immuni.2020.01.001 |
0.454 |
|
| 2019 |
Prasad AN, Ronk AJ, Widen SG, Wood TG, Basler CF, Bukreyev A. Ebola virus produces discrete small non-coding RNAs independent of the host microRNA pathway and which lack RNA interference activity in bat and human cells. Journal of Virology. PMID 31852785 DOI: 10.1128/Jvi.01441-19 |
0.337 |
|
| 2019 |
Younan P, Santos RI, Ramanathan P, Iampietro M, Nishida A, Dutta M, Ammosova T, Meyer M, Katze MG, Popov VL, Nekhai S, Bukreyev A. Ebola virus-mediated T-lymphocyte depletion is the result of an abortive infection. Plos Pathogens. 15: e1008068. PMID 31648236 DOI: 10.1371/Journal.Ppat.1008068 |
0.428 |
|
| 2019 |
Lin X, Ammosova T, Choy MS, Pietzsch CA, Ivanov A, Ahmad A, Saygideğer Y, Kumari N, Kovalskyy D, Üren A, Peti W, Bukreyev A, Nekhai S. Targeting the Non-catalytic RVxF Site of Protein Phosphatase-1 With Small Molecules for Ebola Virus Inhibition. Frontiers in Microbiology. 10: 2145. PMID 31572348 DOI: 10.3389/Fmicb.2019.02145 |
0.393 |
|
| 2019 |
Ivanov A, Ramanathan P, Parry C, Ilinykh PA, Lin X, Petukhov M, Obukhov Y, Ammosova T, Amarasinghe GK, Bukreyev A, Nekhai S. Global phosphoproteomic analysis of Ebola virions reveals a novel role for VP35 phosphorylation-dependent regulation of genome transcription. Cellular and Molecular Life Sciences : Cmls. PMID 31562565 DOI: 10.1007/S00018-019-03303-1 |
0.404 |
|
| 2019 |
Kuhn JH, Amarasinghe GK, Basler CF, Bavari S, Bukreyev A, Chandran K, Crozier I, Dolnik O, Dye JM, Formenty PBH, Griffiths A, Hewson R, Kobinger GP, Leroy EM, Mühlberger E, et al. ICTV Virus Taxonomy Profile: Filoviridae. The Journal of General Virology. PMID 31021739 DOI: 10.1099/Jgv.0.001252 |
0.463 |
|
| 2019 |
King LB, West BR, Moyer CL, Gilchuk P, Flyak A, Ilinykh PA, Bombardi R, Hui S, Huang K, Bukreyev A, Crowe JE, Saphire EO. Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk. Nature Communications. 10: 1788. PMID 30996276 DOI: 10.1038/S41467-019-09732-7 |
0.505 |
|
| 2019 |
West BR, Wec AZ, Moyer CL, Fusco ML, Ilinykh PA, Huang K, Wirchnianski AS, James RM, Herbert AS, Hui S, Goodwin E, Howell KA, Kailasan S, Aman MJ, Walker LM, ... ... Bukreyev A, et al. Structural basis of broad ebolavirus neutralization by a human survivor antibody. Nature Structural & Molecular Biology. PMID 30833785 DOI: 10.1038/S41594-019-0191-4 |
0.447 |
|
| 2018 |
Kimble JB, Malherbe DC, Meyer M, Gunn BM, Karim MM, Ilinykh PA, Iampietro M, Mohamed KS, Negi S, Gilchuk P, Huang K, Wolf YI, Braun W, Crowe JE, Alter G, ... Bukreyev A, et al. ANTIBODY-MEDIATED PROTECTIVE MECHANISMS INDUCED BY A TRIVALENT PARAINFLUENZA-VECTORED EBOLAVIRUS VACCINE. Journal of Virology. PMID 30518655 DOI: 10.1128/Jvi.01845-18 |
0.449 |
|
| 2018 |
Fang J, Pietzsch C, Ramanathan P, Santos RI, Ilinykh PA, Garcia-Blanco MA, Bukreyev A, Bradrick SS. Staufen1 Interacts with Multiple Components of the Ebola Virus Ribonucleoprotein and Enhances Viral RNA Synthesis. Mbio. 9. PMID 30301857 DOI: 10.1128/Mbio.01771-18 |
0.43 |
|
| 2018 |
Younan P, Iampietro M, Santos RI, Ramanathan P, Popov VL, Bukreyev A. Role of Transmembrane Protein 16F in the Incorporation of Phosphatidylserine Into Budding Ebola Virus Virions. The Journal of Infectious Diseases. PMID 30289531 DOI: 10.1093/Infdis/Jiy485 |
0.468 |
|
| 2018 |
Younan P, Iampietro M, Santos RI, Ramanathan P, Popov VL, Bukreyev A. Disruption of Phosphatidylserine Synthesis or Trafficking Reduces Infectivity of Ebola Virus. The Journal of Infectious Diseases. PMID 30289506 DOI: 10.1093/Infdis/Jiy489 |
0.461 |
|
| 2018 |
Meyer M, Malherbe DC, Bukreyev A. Can Ebola Virus Vaccines Have Universal Immune Correlates of protection? Trends in Microbiology. PMID 30201511 DOI: 10.1016/J.Tim.2018.08.008 |
0.415 |
|
| 2018 |
Ammosova T, Pietzsch CA, Saygideger Y, Ilatovsky A, Lin X, Ivanov A, Kumari N, Jerebtsova M, Kulkarni A, Petukhov M, Üren A, Bukreyev A, Nekhai S. Protein Phosphatase 1-Targeting Small-Molecule C31 Inhibits Ebola Virus Replication. The Journal of Infectious Diseases. PMID 30169869 DOI: 10.1093/Infdis/Jiy422 |
0.449 |
|
| 2018 |
Luthra P, Naidoo J, Pietzsch CA, De S, Khadka S, Anantpadma M, Williams CG, Edwards MR, Davey RA, Bukreyev A, Ready JM, Basler CF. Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responses. Antiviral Research. PMID 30144461 DOI: 10.1016/J.Antiviral.2018.08.012 |
0.443 |
|
| 2018 |
Ilinykh PA, Santos RI, Gunn BM, Kuzmina NA, Shen X, Huang K, Gilchuk P, Flyak AI, Younan P, Alter G, Crowe JE, Bukreyev A. Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap. Plos Pathogens. 14: e1007204. PMID 30138408 DOI: 10.1371/Journal.Ppat.1007204 |
0.486 |
|
| 2018 |
Tigabu B, Ramanathan P, Ivanov A, Lin X, Ilinykh PA, Parry CS, Freiberg AN, Nekhai S, Bukreyev A. PHOSPHORYLATED VP30 OF MARBURG VIRUS IS A REPRESSOR OF TRANSCRIPTION. Journal of Virology. PMID 30135121 DOI: 10.1128/Jvi.00426-18 |
0.365 |
|
| 2018 |
Meyer M, Yoshida A, Ramanathan P, Saphire EO, Collins PL, Crowe JE, Samal S, Bukreyev A. Antibody Repertoires to the Same Ebola Vaccine Antigen Are Differentially Affected by Vaccine Vectors. Cell Reports. 24: 1816-1829. PMID 30110638 DOI: 10.1016/J.Celrep.2018.07.044 |
0.433 |
|
| 2018 |
Kuzmina NA, Younan P, Gilchuk P, Santos RI, Flyak AI, Ilinykh PA, Huang K, Lubaki NM, Ramanathan P, Crowe JE, Bukreyev A. Antibody-Dependent Enhancement of Ebola Virus Infection by Human Antibodies Isolated from Survivors. Cell Reports. 24: 1802-1815.e5. PMID 30110637 DOI: 10.1016/J.Celrep.2018.07.035 |
0.398 |
|
| 2018 |
Saphire EO, Schendel SL, Fusco ML, Gangavarapu K, Gunn BM, Wec AZ, Halfmann PJ, Brannan JM, Herbert AS, Qiu X, Wagh K, He S, Giorgi EE, Theiler J, Pommert KBJ, ... ... Bukreyev A, et al. Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection. Cell. 174: 938-952.e13. PMID 30096313 DOI: 10.1016/J.Cell.2018.07.033 |
0.488 |
|
| 2018 |
Iampietro M, Santos RI, Lubaki NM, Bukreyev A. Ebola Virus Shed Glycoprotein Triggers Differentiation, Infection, and Death of Monocytes Through Toll-Like Receptor 4 Activation. The Journal of Infectious Diseases. PMID 30085081 DOI: 10.1093/Infdis/Jiy406 |
0.518 |
|
| 2018 |
Ilinykh PA, Graber J, Kuzmina NA, Huang K, Ksiazek TG, Crowe JE, Bukreyev A. Ebolavirus Chimerization for the Development of a Mouse Model for Screening of Bundibugyo-Specific Antibodies. The Journal of Infectious Diseases. PMID 30060231 DOI: 10.1093/Infdis/Jiy423 |
0.493 |
|
| 2018 |
Gilchuk P, Kuzmina N, Ilinykh PA, Huang K, Gunn BM, Bryan A, Davidson E, Doranz BJ, Turner HL, Fusco ML, Bramble MS, Hoff NA, Binshtein E, Kose N, Flyak AI, ... ... Bukreyev A, et al. Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein. Immunity. PMID 30029854 DOI: 10.1016/J.Immuni.2018.06.018 |
0.465 |
|
| 2018 |
Flyak AI, Kuzmina N, Murin CD, Bryan C, Davidson E, Gilchuk P, Gulka CP, Ilinykh PA, Shen X, Huang K, Ramanathan P, Turner H, Fusco ML, Lampley R, Kose N, ... ... Bukreyev A, et al. Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2-MPER region. Nature Microbiology. PMID 29736037 DOI: 10.1038/S41564-018-0157-Z |
0.492 |
|
| 2018 |
Younan P, Iampietro M, Bukreyev A. Disabling of lymphocyte immune response by Ebola virus. Plos Pathogens. 14: e1006932. PMID 29649305 DOI: 10.1371/Journal.Ppat.1006932 |
0.449 |
|
| 2018 |
King LB, Fusco ML, Flyak AI, Ilinykh PA, Huang K, Gunn B, Kirchdoerfer RN, Hastie KM, Sangha AK, Meiler J, Alter G, Bukreyev A, Crowe JE, Saphire EO. The Marburgvirus-Neutralizing Human Monoclonal Antibody MR191 Targets a Conserved Site to Block Virus Receptor Binding. Cell Host & Microbe. 23: 101-109.e4. PMID 29324225 DOI: 10.1016/J.Chom.2017.12.003 |
0.409 |
|
| 2017 |
Luthra P, Liang J, Pietzsch CA, Khadka S, Edwards MR, Wei S, De S, Posner B, Bukreyev A, Ready JM, Basler CF. A high throughput screen identifies benzoquinoline compounds as inhibitors of Ebola virus replication. Antiviral Research. PMID 29294299 DOI: 10.1016/J.Antiviral.2017.12.019 |
0.431 |
|
| 2017 |
Meyer M, Huang E, Yuzhakov O, Ramanathan P, Ciaramella G, Bukreyev A. Modified mRNA-Based Vaccines Elicit Robust Immune Responses and Protect Guinea Pigs From Ebola Virus Disease. The Journal of Infectious Diseases. PMID 29281112 DOI: 10.1093/Infdis/Jix592 |
0.429 |
|
| 2017 |
Younan P, Iampietro M, Nishida A, Ramanathan P, Santos RI, Dutta M, Lubaki NM, Koup RA, Katze MG, Bukreyev A. Ebola Virus Binding to Tim-1 on T Lymphocytes Induces a Cytokine Storm. Mbio. 8. PMID 28951472 DOI: 10.1128/Mbio.00845-17 |
0.402 |
|
| 2017 |
Iampietro M, Younan P, Nishida A, Dutta M, Lubaki NM, Santos RI, Koup RA, Katze MG, Bukreyev A. Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection. Plos Pathogens. 13: e1006397. PMID 28542576 DOI: 10.1371/Journal.Ppat.1006397 |
0.372 |
|
| 2017 |
Younan P, Ramanathan P, Graber J, Gusovsky F, Bukreyev A. The Toll-Like Receptor 4 Antagonist Eritoran Protects Mice from Lethal Filovirus Challenge. Mbio. 8. PMID 28442605 DOI: 10.1128/Mbio.00226-17 |
0.435 |
|
| 2017 |
Luthra P, Aguirre S, Yen BC, Pietzsch CA, Sanchez-Aparicio MT, Tigabu B, Morlock LK, García-Sastre A, Leung DW, Williams NS, Fernandez-Sesma A, Bukreyev A, Basler CF. Topoisomerase II Inhibitors Induce DNA Damage-Dependent Interferon Responses Circumventing Ebola Virus Immune Evasion. Mbio. 8. PMID 28377530 DOI: 10.1128/Mbio.00368-17 |
0.461 |
|
| 2017 |
Liu G, Nash PJ, Johnson B, Pietzsch C, Ilagan MG, Bukreyev A, Basler CF, Bowlin TL, Moir DT, Leung DW, Amarasinghe GK. A Sensitive In Vitro High-Throughput Screen to Identify Pan-Filoviral Replication Inhibitors Targeting the VP35-NP Interface. Acs Infectious Diseases. PMID 28152588 DOI: 10.1021/Acsinfecdis.6B00209 |
0.373 |
|
| 2017 |
Kuzmin IV, Schwarz TM, Ilinykh PA, Jordan I, Ksiazek TG, Sachidanandam R, Basler CF, Bukreyev A. Innate Immune Response of Bat and Human Cells to Filoviruses: Commonalities and Distinctions. Journal of Virology. PMID 28122983 DOI: 10.1128/Jvi.02471-16 |
0.457 |
|
| 2016 |
Lubaki NM, Younan P, Santos RI, Meyer M, Iampietro M, Koup RA, Bukreyev A. The Ebola Interferon Inhibiting Domains Attenuate and Dysregulate Cell-Mediated Immune Responses. Plos Pathogens. 12: e1006031. PMID 27930745 DOI: 10.1371/Journal.Ppat.1006031 |
0.414 |
|
| 2016 |
Postler TS, Clawson AN, Amarasinghe GK, Basler CF, Bavari S, Benkő M, Blasdell KR, Briese T, Buchmeier MJ, Bukreyev A, Calisher CH, Chandran K, Charrel R, Clegg CS, Collins PL, et al. Possibility and Challenges of Conversion of Current Virus Species Names to Linnaean Binomials. Systematic Biology. PMID 27798405 DOI: 10.1093/Sysbio/Syw096 |
0.385 |
|
| 2016 |
Norris EL, Headlam MJ, Dave KA, Smith DD, Bukreyev A, Singh T, Jayakody BA, Chappell KJ, Collins PL, Gorman JJ. Proteoform-specific insights into cellular proteome regulation. Molecular & Cellular Proteomics : McP. PMID 27451424 DOI: 10.1074/Mcp.O116.058438 |
0.428 |
|
| 2016 |
Rialdi A, Campisi L, Zhao N, Lagda AC, Pietzsch C, Ho JS, Martinez-Gil L, Fenouil R, Chen X, Edwards M, Metreveli G, Jordan S, Peralta Z, Munoz-Fontela C, Bouvier N, ... ... Bukreyev A, et al. Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation. Science (New York, N.Y.). PMID 27127234 DOI: 10.1126/Science.Aad7993 |
0.375 |
|
| 2016 |
Ilinykh PA, Shen X, Flyak AI, Kuzmina N, Ksiazek TG, Crowe JE, Bukreyev A. Chimeric Filoviruses for Identification and Characterization of Monoclonal Antibodies. Journal of Virology. PMID 26819310 DOI: 10.1128/Jvi.00101-16 |
0.516 |
|
| 2016 |
Flyak AI, Shen X, Murin CD, Turner HL, David JA, Fusco ML, Lampley R, Kose N, Ilinykh PA, Kuzmina N, Branchizio A, King H, Brown L, Bryan C, Davidson E, ... ... Bukreyev A, et al. Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection. Cell. PMID 26806128 DOI: 10.1016/J.Cell.2015.12.022 |
0.489 |
|
| 2015 |
Edwards MR, Pietzsch C, Vausselin T, Shaw ML, Bukreyev A, Basler CF. High-Throughput Minigenome System for Identifying Small-Molecule Inhibitors of Ebola Virus Replication. Acs Infectious Diseases. 1: 380-387. PMID 26284260 DOI: 10.1021/Acsinfecdis.5B00053 |
0.421 |
|
| 2015 |
Meyer M, Garron T, Lubaki NM, Mire CE, Fenton KA, Klages C, Olinger GG, Geisbert TW, Collins PL, Bukreyev A. Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responses. The Journal of Clinical Investigation. 125: 3241-55. PMID 26168222 DOI: 10.1172/Jci81532 |
0.421 |
|
| 2015 |
Russell RF, McDonald JU, Ivanova M, Zhong Z, Bukreyev A, Tregoning JS. The partial attenuation of Small Hydrophobic (SH) gene deleted RSV is associated with elevated IL-1β responses. Journal of Virology. PMID 26085154 DOI: 10.1128/Jvi.01070-15 |
0.393 |
|
| 2015 |
Ilinykh PA, Lubaki NM, Widen SG, Renn LA, Theisen TC, Rabin RL, Wood TG, Bukreyev A. Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells. Journal of Virology. 89: 7567-83. PMID 25972536 DOI: 10.1128/Jvi.00924-15 |
0.405 |
|
| 2015 |
Flyak AI, Ilinykh PA, Murin CD, Garron T, Shen X, Fusco ML, Hashiguchi T, Bornholdt ZA, Slaughter JC, Sapparapu G, Klages C, Ksiazek TG, Ward AB, Saphire EO, Bukreyev A, et al. Mechanism of human antibody-mediated neutralization of Marburg virus. Cell. 160: 893-903. PMID 25723164 DOI: 10.1016/J.Cell.2015.01.031 |
0.413 |
|
| 2014 |
Dave KA, Norris EL, Bukreyev AA, Headlam MJ, Buchholz UJ, Singh T, Collins PL, Gorman JJ. A comprehensive proteomic view of responses of A549 type II alveolar epithelial cells to human respiratory syncytial virus infection. Molecular & Cellular Proteomics : McP. 13: 3250-69. PMID 25106423 DOI: 10.1074/mcp.M114.041129 |
0.371 |
|
| 2014 |
Ilinykh PA, Tigabu B, Ivanov A, Ammosova T, Obukhov Y, Garron T, Kumari N, Kovalskyy D, Platonov MO, Naumchik VS, Freiberg AN, Nekhai S, Bukreyev A. Role of protein phosphatase 1 in dephosphorylation of Ebola virus VP30 protein and its targeting for the inhibition of viral transcription. The Journal of Biological Chemistry. 289: 22723-38. PMID 24936058 DOI: 10.1074/Jbc.M114.575050 |
0.406 |
|
| 2014 |
Tigabu B, Rasmussen L, White EL, Tower N, Saeed M, Bukreyev A, Rockx B, LeDuc JW, Noah JW. A BSL-4 high-throughput screen identifies sulfonamide inhibitors of Nipah virus. Assay and Drug Development Technologies. 12: 155-61. PMID 24735442 DOI: 10.1089/Adt.2013.567 |
0.392 |
|
| 2014 |
Kuhn JH, Bào Y, Bavari S, Becker S, Bradfute S, Brauburger K, Rodney Brister J, Bukreyev AA, Caì Y, Chandran K, Davey RA, Dolnik O, Dye JM, Enterlein S, Gonzalez JP, et al. Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA. Archives of Virology. 159: 1229-37. PMID 24190508 DOI: 10.1007/S00705-013-1877-2 |
0.372 |
|
| 2013 |
Lubaki NM, Ilinykh P, Pietzsch C, Tigabu B, Freiberg AN, Koup RA, Bukreyev A. The lack of maturation of Ebola virus-infected dendritic cells results from the cooperative effect of at least two viral domains. Journal of Virology. 87: 7471-85. PMID 23616668 DOI: 10.1128/Jvi.03316-12 |
0.409 |
|
| 2013 |
Tregoning JS, Wang BL, McDonald JU, Yamaguchi Y, Harker JA, Goritzka M, Johansson C, Bukreyev A, Collins PL, Openshaw PJ. Neonatal antibody responses are attenuated by interferon-γ produced by NK and T cells during RSV infection. Proceedings of the National Academy of Sciences of the United States of America. 110: 5576-81. PMID 23509276 DOI: 10.1073/Pnas.1214247110 |
0.451 |
|
| 2012 |
Bukreyev A, Yang L, Collins PL. The secreted G protein of human respiratory syncytial virus antagonizes antibody-mediated restriction of replication involving macrophages and complement. Journal of Virology. 86: 10880-4. PMID 22837211 DOI: 10.1128/Jvi.01162-12 |
0.451 |
|
| 2011 |
Munir S, Hillyer P, Le Nouën C, Buchholz UJ, Rabin RL, Collins PL, Bukreyev A. Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response. Plos Pathogens. 7: e1001336. PMID 21533073 DOI: 10.1371/Journal.Ppat.1001336 |
0.354 |
|
| 2010 |
Le Nouën C, Hillyer P, Munir S, Winter CC, McCarty T, Bukreyev A, Collins PL, Rabin RL, Buchholz UJ. Effects of human respiratory syncytial virus, metapneumovirus, parainfluenza virus 3 and influenza virus on CD4+ T cell activation by dendritic cells. Plos One. 5: e15017. PMID 21124776 DOI: 10.1371/Journal.Pone.0015017 |
0.51 |
|
| 2010 |
DiNapoli JM, Yang L, Samal SK, Murphy BR, Collins PL, Bukreyev A. Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response. Vaccine. 29: 17-25. PMID 21034822 DOI: 10.1016/J.Vaccine.2010.10.024 |
0.516 |
|
| 2010 |
Harker JA, Lee DC, Yamaguchi Y, Wang B, Bukreyev A, Collins PL, Tregoning JS, Openshaw PJ. Delivery of cytokines by recombinant virus in early life alters the immune response to adult lung infection. Journal of Virology. 84: 5294-302. PMID 20200251 DOI: 10.1128/Jvi.02503-09 |
0.44 |
|
| 2010 |
Harker JA, Godlee A, Wahlsten JL, Lee DC, Thorne LG, Sawant D, Tregoning JS, Caspi RR, Bukreyev A, Collins PL, Openshaw PJ. Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells. Journal of Virology. 84: 4073-82. PMID 20130064 DOI: 10.1128/Jvi.02014-09 |
0.436 |
|
| 2010 |
Bukreyev AA, Dinapoli JM, Yang L, Murphy BR, Collins PL. Mucosal parainfluenza virus-vectored vaccine against Ebola virus replicates in the respiratory tract of vector-immune monkeys and is immunogenic. Virology. 399: 290-8. PMID 20129638 DOI: 10.1016/j.virol.2010.01.015 |
0.45 |
|
| 2010 |
DiNapoli JM, Nayak B, Yang L, Finneyfrock BW, Cook A, Andersen H, Torres-Velez F, Murphy BR, Samal SK, Collins PL, Bukreyev A. Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys. Journal of Virology. 84: 1489-503. PMID 19923177 DOI: 10.1128/Jvi.01946-09 |
0.504 |
|
| 2009 |
DiNapoli JM, Ward JM, Cheng L, Yang L, Elankumaran S, Murphy BR, Samal SK, Collins PL, Bukreyev A. Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans. Vaccine. 27: 1530-9. PMID 19168110 DOI: 10.1016/J.Vaccine.2009.01.009 |
0.43 |
|
| 2009 |
Le Nouën C, Munir S, Losq S, Winter CC, McCarty T, Stephany DA, Holmes KL, Bukreyev A, Rabin RL, Collins PL, Buchholz UJ. Infection and maturation of monocyte-derived human dendritic cells by human respiratory syncytial virus, human metapneumovirus, and human parainfluenza virus type 3. Virology. 385: 169-82. PMID 19128816 DOI: 10.1016/J.Virol.2008.11.043 |
0.509 |
|
| 2009 |
Bukreyev A, Marzi A, Feldmann F, Zhang L, Yang L, Ward JM, Dorward DW, Pickles RJ, Murphy BR, Feldmann H, Collins PL. Chimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challenge. Virology. 383: 348-61. PMID 19010509 DOI: 10.1016/J.Virol.2008.09.030 |
0.519 |
|
| 2008 |
Bukreyev A, Yang L, Fricke J, Cheng L, Ward JM, Murphy BR, Collins PL. The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes Journal of Virology. 82: 12191-12204. PMID 18842713 DOI: 10.1128/Jvi.01604-08 |
0.444 |
|
| 2008 |
DiNapoli JM, Murphy BR, Collins PL, Bukreyev A. Impairment of the CD8+ T cell response in lungs following infection with human respiratory syncytial virus is specific to the anatomical site rather than the virus, antigen, or route of infection Virology Journal. 5. PMID 18816384 DOI: 10.1186/1743-422X-5-105 |
0.502 |
|
| 2008 |
Collins PL, Bukreyev A, Murphy BR. What are the risks - hypothetical and observed - of recombination involving live vaccines and vaccine vectors based on nonsegmented negative-strain RNA viruses? Journal of Virology. 82: 9805-9806. PMID 18796655 DOI: 10.1128/Jvi.01336-08 |
0.496 |
|
| 2008 |
Yang L, Sanchez A, Ward JM, Murphy BR, Collins PL, Bukreyev A. A paramyxovirus-vectored intranasal vaccine against Ebola virus is immunogenic in vector-immune animals Virology. 377: 255-264. PMID 18570964 DOI: 10.1016/J.Virol.2008.04.029 |
0.539 |
|
| 2008 |
Munir S, Le Nouen C, Luongo C, Buchholz UJ, Collins PL, Bukreyev A. Nonstructural proteins 1 and 2 of respiratory syncytial virus suppress maturation of human dendritic cells. Journal of Virology. 82: 8780-96. PMID 18562519 DOI: 10.1128/Jvi.00630-08 |
0.453 |
|
| 2008 |
Bukreyev A, Collins PL. Newcastle disease virus as a vaccine vector for humans Current Opinion in Molecular Therapeutics. 10: 46-55. PMID 18228181 |
0.414 |
|
| 2007 |
Harker J, Bukreyev A, Collins PL, Wang B, Openshaw PJM, Tregoning JS. Virally delivered cytokines alter the immune response to future lung infections Journal of Virology. 81: 13105-13111. PMID 17855518 DOI: 10.1128/Jvi.01544-07 |
0.466 |
|
| 2007 |
DiNapoli JM, Yang L, Suguitan A, Elankumaran S, Dorward DW, Murphy BR, Samal SK, Collins PL, Bukreyev A. Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus. Journal of Virology. 81: 11560-8. PMID 17715243 DOI: 10.1128/Jvi.00713-07 |
0.518 |
|
| 2007 |
DiNapoli JM, Kotelkin A, Yang L, Elankumaran S, Murphy BR, Samal SK, Collins PL, Bukreyev A. Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens. Proceedings of the National Academy of Sciences of the United States of America. 104: 9788-93. PMID 17535926 DOI: 10.1073/Pnas.0703584104 |
0.504 |
|
| 2007 |
Bukreyev A, Rollin PE, Tate MK, Yang L, Zaki SR, Shieh WJ, Murphy BR, Collins PL, Sanchez A. Successful topical respiratory tract immunization of primates against Ebola virus. Journal of Virology. 81: 6379-88. PMID 17428868 DOI: 10.1128/Jvi.00105-07 |
0.563 |
|
| 2006 |
Bukreyev A, Skiadopoulos MH, Murphy BR, Collins PL. Nonsegmented negative-strand viruses as vaccine vectors Journal of Virology. 80: 10293-10306. PMID 17041210 DOI: 10.1128/Jvi.00919-06 |
0.545 |
|
| 2006 |
Kotelkin A, Belyakov IM, Yang L, Berzofsky JA, Collins PL, Bukreyev A. The NS2 protein of human respiratory syncytial virus suppresses the cytotoxic T-cell response as a consequence of suppressing the type I interferon response Journal of Virology. 80: 5958-5967. PMID 16731934 DOI: 10.1128/Jvi.00181-06 |
0.41 |
|
| 2006 |
Bukreyev A, Serra ME, Laham FR, Melendi GA, Kleeberger SR, Collins PL, Polack FP. The cysteine-rich region and secreted form of the attachment G glycoprotein of respiratory syncytial virus enhance the cytotoxic T-lymphocyte response despite lacking major histocompatibility complex class I-restricted epitopes Journal of Virology. 80: 5854-5861. PMID 16731924 DOI: 10.1128/Jvi.02671-05 |
0.468 |
|
| 2006 |
Bukreyev A, Yang L, Zaki SR, Shieh WJ, Rollin PE, Murphy BR, Collins PL, Sanchez A. A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challenge. Journal of Virology. 80: 2267-79. PMID 16474134 DOI: 10.1128/Jvi.80.5.2267-2279.2006 |
0.532 |
|
| 2006 |
Kotelkin A, Belyakov IM, Yang L, Berzofsky JA, Collins PL, Bukreyev A. Erratum: The NS2 protein of human respiratory syncytial virus suppresses the cytotoxic T-cell response as a consequence of suppressing the type I interferon response (Journal of Virology (2006) 80, 12 (5958-5967)) Journal of Virology. 80. DOI: 10.1128/Jvi.01773-06 |
0.437 |
|
| 2005 |
Bukreyev A, Huang Z, Yang L, Elankumaran S, St Claire M, Murphy BR, Samal SK, Collins PL. Recombinant newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates. Journal of Virology. 79: 13275-84. PMID 16227250 DOI: 10.1128/Jvi.79.21.13275-13284.2005 |
0.547 |
|
| 2005 |
Bukreyev A, Belyakov IM, Prince GA, Yim KC, Harris KK, Berzofsky JA, Collins PL. Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus. Journal of Virology. 79: 9515-26. PMID 16014914 DOI: 10.1128/Jvi.79.15.9515-9526.2005 |
0.432 |
|
| 2005 |
Zhang L, Bukreyev A, Thompson CI, Watson B, Peeples ME, Collins PL, Pickles RJ. Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium. Journal of Virology. 79: 1113-24. PMID 15613339 DOI: 10.1128/Jvi.79.2.1113-1124.2005 |
0.479 |
|
| 2004 |
Bukreyev A, Lamirande EW, Buchholz UJ, Vogel LN, Elkins WR, St Claire M, Murphy BR, Subbarao K, Collins PL. Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS. Lancet (London, England). 363: 2122-7. PMID 15220033 DOI: 10.1016/S0140-6736(04)16501-X |
0.431 |
|
| 2004 |
Buchholz UJ, Bukreyev A, Yang L, Lamirande EW, Murphy BR, Subbarao K, Collins PL. Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. Proceedings of the National Academy of Sciences of the United States of America. 101: 9804-9. PMID 15210961 DOI: 10.1073/Pnas.0403492101 |
0.441 |
|
| 2004 |
Bisht H, Roberts A, Vogel L, Bukreyev A, Collins PL, Murphy BR, Subbarao K, Moss B. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proceedings of the National Academy of Sciences of the United States of America. 101: 6641-6. PMID 15096611 DOI: 10.1073/Pnas.0401939101 |
0.423 |
|
| 2002 |
Bukreyev A, Belyakov IM. Expression of immunomodulating molecules by recombinant viruses: can the immunogenicity of live virus vaccines be improved? Expert Review of Vaccines. 1: 233-45. PMID 12901562 DOI: 10.1586/14760584.1.2.233 |
0.475 |
|
| 2002 |
Bukreyev A, Skiadopoulos MH, McAuliffe J, Murphy BR, Collins PL, Schmidt AC. More antibody with less antigen: Can immunogenicity of attenuated live virus vaccines be improved? Proceedings of the National Academy of Sciences of the United States of America. 99: 16987-16991. PMID 12482928 DOI: 10.1073/Pnas.252649299 |
0.551 |
|
| 2002 |
Sorokin AV, Kazachinskaia EI, Ivanova AV, Kachko AV, Netesov SV, Bukreyev A, Loktev VB, Razumov IA. Mapping of two dominant sites of VP35 of Marburg virus. Viral Immunology. 15: 481-492. PMID 12479397 DOI: 10.1089/088282402760312359 |
0.395 |
|
| 2002 |
Kachko AV, Sorokin AV, Belanov EF, Ivanova AV, Bukreyev A, Collins P, Netesov SV. The study of transcription and replication of the Marburg virus using a minireplicon system constructed on the basis of viral genome [corrected]. Doklady Biochemistry and Biophysics. 383: 108-112. PMID 12058361 DOI: 10.1023/A:1015383618008 |
0.474 |
|
| 2001 |
Bukreyev A, Belyakov IM, Berzofsky JA, Murphy BR, Collins PL. Granulocyte-Macrophage Colony-Stimulating Factor Expressed by Recombinant Respiratory Syncytial Virus Attenuates Viral Replication and Increases the Level of Pulmonary Antigen-Presenting Cells Journal of Virology. 75: 12128-12140. PMID 11711604 DOI: 10.1128/Jvi.75.24.12128-12140.2001 |
0.488 |
|
| 2000 |
Bukreyev A, Murphy BR, Collins PL. Respiratory Syncytial Virus Can Tolerate an Intergenic Sequence of at Least 160 Nucleotides with Little Effect on Transcription or Replication In Vitro and In Vivo Journal of Virology. 74: 11017-11026. PMID 11069997 DOI: 10.1128/Jvi.74.23.11017-11026.2000 |
0.485 |
|
| 2000 |
Bukreyev A, Whitehead SS, Prussin C, Murphy BR, Collins PL. Effect of coexpression of interleukin-2 by recombinant respiratory syncytial virus on virus replication, immunogenicity, and production of other cytokines. Journal of Virology. 74: 7151-7. PMID 10888656 DOI: 10.1128/Jvi.74.15.7151-7157.2000 |
0.414 |
|
| 1999 |
Collins PL, Whitehead SS, Bukreyev A, Fearns R, Teng MN, Juhasz K, Chanock RM, Murphy BR. Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics. Advances in Virus Research. 54: 423-51. PMID 10547682 DOI: 10.1016/S0065-3527(08)60374-7 |
0.473 |
|
| 1999 |
Whitehead SS, Bukreyev A, Teng MN, Firestone CY, St Claire M, Elkins WR, Collins PL, Murphy BR. Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees. Journal of Virology. 73: 3438-42. PMID 10074199 DOI: 10.1128/Jvi.73.4.3438-3442.1999 |
0.498 |
|
| 1999 |
Bukreyev A, Whitehead SS, Bukreyeva N, Murphy BR, Collins PL. Interferon gamma expressed by a recombinant respiratory syncytial virus attenuates virus replication in mice without compromising immunogenicity. Proceedings of the National Academy of Sciences of the United States of America. 96: 2367-72. PMID 10051648 DOI: 10.1073/Pnas.96.5.2367 |
0.428 |
|
| 1999 |
Beer B, Kurth R, Bukreyev A. Characteristics of Filoviridae: Marburg and Ebola viruses. Die Naturwissenschaften. 86: 8-17. PMID 10024977 DOI: 10.1007/S001140050562 |
0.478 |
|
| 1997 |
Bukreyev A, Whitehead SS, Murphy BR, Collins PL. Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse. Journal of Virology. 71: 8973-82. PMID 9371553 DOI: 10.1128/Jvi.71.12.8973-8982.1997 |
0.482 |
|
| 1996 |
Bukreyev A, Camargo E, Collins PL. Recovery of Infectious Respiratory Syncytial Virus Expressing an Additional, Foreign Gene Journal of Virology. 70: 6634-6641. PMID 8794298 DOI: 10.1128/Jvi.70.10.6634-6641.1996 |
0.406 |
|
| 1995 |
Bukreyev A, Volchkov VE, Blinov VM, Dryga SA, Netesov SV. The complete nucleotide sequence of the Popp (1967) strain of Marburg virus: a comparison with the Musoke (1980) strain Archives of Virology. 140: 1589-1600. PMID 7487490 DOI: 10.1007/Bf01322532 |
0.353 |
|
| 1993 |
Bukreyev A, Volchkov VE, Blinov VM, Netesov SV. The GP-protein of Marburg virus contains the region similar to the 'immunosuppressive domain' of oncogenic retrovirus P15E proteins Febs Letters. 323: 183-187. PMID 8495737 DOI: 10.1016/0014-5793(93)81476-G |
0.408 |
|
| 1993 |
Bukreyev A, Volchkov VE, Blinov VM, Netesov SV. The VP35 and VP40 proteins of filoviruses: Homology between Marburg and Ebola viruses Febs Letters. 322: 41-46. PMID 8482365 DOI: 10.1016/0014-5793(93)81107-B |
0.327 |
|
| Show low-probability matches. |